Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [335]
News [1545]
Articles [67]
Editorials [3]
Conferences [72]
elearning [15]
POLO Trial: Olaparib as a maintenance treatment following first-line...
Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona...
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer ( Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain )
6 Jun 2019
Highlights from ASCO 2019
Asst. Prof Bishal Gyawali and Monique Biryiana
Highlights from ASCO 2019 ( Asst. Prof Bishal Gyawali and Monique Biryiana )
3 Jun 2019
PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA...
Dr Hedy Kindler - University of Chicago, Chicago, USA
PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA gene mutations ( Dr Hedy Kindler - University of Chicago, Chicago, USA )
2 Jun 2019
Maintenance therapy with PARP inhibitor olaparib delays progression in patients...
Dr Hedy Kindler - University of Chicago, Chicago, USA
Maintenance therapy with PARP inhibitor olaparib delays progression in patients with BRCA-related pancreatic cancer ( Dr Hedy Kindler - University of Chicago, Chicago, USA )
2 Jun 2019
Comment: It is essential to identify the BRCA gene in pancreatic cancer...
Dr Suzanne Cole - UT Southwestern Medical Center, Dallas, USA
Comment: It is essential to identify the BRCA gene in pancreatic cancer patients allowing them to be treated with an oral agent ( Dr Suzanne Cole - UT Southwestern Medical Center, Dallas, USA )
2 Jun 2019
Epigenetic expression in T cell leukaemia
Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA
Epigenetic expression in T cell leukaemia ( Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA )
24 May 2019
B-lymphoid transcriptional programme as a barrier against malignant...
Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA
B-lymphoid transcriptional programme as a barrier against malignant transformation in acute lymphoblastic leukaemia ( Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA )
24 May 2019
Emerging role of radioembolization for hepatocellular carcinoma
Prof Riad Salem - Northwestern University, Chicago, USA
Emerging role of radioembolization for hepatocellular carcinoma ( Prof Riad Salem - Northwestern University, Chicago, USA )
8 May 2019
Advanced HCC: New systemic treatment options
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019
Surgical management of pancreatic cancer
Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia
Surgical management of pancreatic cancer ( Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia )
8 May 2019
Highlights from IGILUC 2019
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019
PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation